Fundraising Fox

Elucida Oncology

New York, US · Founded 2014 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

GG
Geno GermanoChief Executive Officer
MT
Michael T. SmithNamed on SEC filing
TB
Tim BorisNamed on SEC filing
RA
Robert A. RuffoloNamed on SEC filing
TM
Teresa M. ResselNamed on SEC filing
UW
Ulrich WiesnerNamed on SEC filing
RA
Robert A. EssnerNamed on SEC filing
IB
Isaac BlechNamed on SEC filing

Investors · 1

OphthaFundCharlestonvia Tom Mather · inferred

Reported raises · per SEC filings

Form D private placements

$117.1M disclosed across 5 rounds · 2017–2023

▶$22.3MraisedAug 2023 · 107 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tim BorisDirector
  • Robert RuffoloDirector
  • David ZacardelliDirector
  • Ulrich WiesnerDirector
  • Gary SenderDirector
  • Robert EssnerExecutive Officer, Director
  • Natalie MacDonaldDirector
  • Geno GermanoExecutive Officer, Director
Offering amount
$22.3M
Amount sold
$22.3M
Sales commissions
$2.2M
Placement agents
Maxim Group LLC
First sale
May 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$22.3MraisedMar 2022 · 107 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kai MaExecutive Officer
  • Eliel BayeverExecutive Officer
  • Gary SenderDirector
  • Geno GermanoExecutive Officer, Director
  • Robert RuffoloDirector
  • Somaiya IanExecutive Officer
  • Tim BorisDirector
  • Robert EssnerExecutive Officer, Director
  • David ZacardelliDirector
  • Gregory AdamsExecutive Officer
  • Ulrich WiesnerDirector
  • Natalie MacDonaldDirector
Offering amount
$22.3M
Amount sold
$22.3M
Minimum investment
$100K
Sales commissions
$2.2M
Placement agents
Maxim Group LLC
First sale
Mar 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$35MraisedJan 2021 · 328 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tim BorisDirector
  • Michael SmithDirector
  • Robert EssnerExecutive Officer, Director
  • Teresa ResselDirector
  • Robert RuffoloDirector
  • Gregory AdamsExecutive Officer
  • Kai MaExecutive Officer
  • Eliel BayeverExecutive Officer
  • Geno GermanoExecutive Officer, Director
  • Ulrich WiesnerDirector
Offering amount
$35M
Amount sold
$35M
Minimum investment
$12.5K
Sales commissions
$3.5M
Placement agents
Maxim Group LLC
First sale
Oct 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.8MraisedJun 2020 · 126 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael SmithDirector
  • Robert RuffoloDirector
  • Robert EssnerExecutive Officer, Director
  • Ulrich WiesnerDirector
  • Geno GermanoExecutive Officer, Director
  • Tim BorisDirector
  • Teresa ResselDirector
Offering amount
$30M
Amount sold
$8.8M
Minimum investment
$11.4K
Sales commissions
$774.1K
Placement agents
Maxim Group LLC
First sale
May 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$28.8MraisedFeb 2019 · 175 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael T. SmithDirector
  • Tim BorisDirector
  • Geno GermanoExecutive Officer, Director
  • Robert A. RuffoloDirector
  • Teresa M. ResselDirector
  • Ulrich WiesnerDirector
  • Robert A. EssnerDirector
  • Isaac BlechDirector
Offering amount
$30M
Amount sold
$28.8M
Minimum investment
$25K
Sales commissions
$2.9M
Proceeds to insiders
$400K
Placement agents
Maxim Group LLC
First sale
Aug 2017
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Elucida Oncology's investors?
Elucida Oncology's investors include OphthaFund.
How much funding has Elucida Oncology raised?
Elucida Oncology has disclosed $117.1M raised across 5 rounds.
Where is Elucida Oncology headquartered?
Elucida Oncology is headquartered in New York, US.